Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9ARI6
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 7 |
GO:0016043 | cellular component organization | 3 | 7 |
GO:0022607 | cellular component assembly | 4 | 7 |
GO:0043933 | protein-containing complex organization | 4 | 7 |
GO:0051259 | protein complex oligomerization | 6 | 7 |
GO:0051260 | protein homooligomerization | 7 | 7 |
GO:0065003 | protein-containing complex assembly | 5 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 113 | 117 | PF00656 | 0.299 |
CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.416 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.657 |
CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.602 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.411 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.602 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.562 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.746 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.583 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.513 |
DEG_APCC_DBOX_1 | 36 | 44 | PF00400 | 0.411 |
DOC_CYCLIN_RxL_1 | 276 | 283 | PF00134 | 0.508 |
DOC_CYCLIN_yClb3_PxF_3 | 162 | 168 | PF00134 | 0.465 |
DOC_MAPK_DCC_7 | 226 | 236 | PF00069 | 0.538 |
DOC_MAPK_gen_1 | 277 | 284 | PF00069 | 0.541 |
DOC_MAPK_MEF2A_6 | 277 | 284 | PF00069 | 0.600 |
DOC_PP1_RVXF_1 | 240 | 247 | PF00149 | 0.636 |
DOC_PP2B_LxvP_1 | 282 | 285 | PF13499 | 0.508 |
DOC_PP2B_LxvP_1 | 86 | 89 | PF13499 | 0.411 |
DOC_PP4_FxxP_1 | 169 | 172 | PF00568 | 0.599 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.557 |
LIG_14-3-3_CanoR_1 | 157 | 162 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 208 | 216 | PF00244 | 0.725 |
LIG_14-3-3_CanoR_1 | 279 | 285 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 36 | 41 | PF00244 | 0.513 |
LIG_14-3-3_CanoR_1 | 85 | 89 | PF00244 | 0.436 |
LIG_APCC_ABBAyCdc20_2 | 242 | 248 | PF00400 | 0.640 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.514 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.366 |
LIG_CSL_BTD_1 | 135 | 138 | PF09270 | 0.471 |
LIG_EVH1_2 | 164 | 168 | PF00568 | 0.471 |
LIG_FHA_1 | 189 | 195 | PF00498 | 0.812 |
LIG_FHA_1 | 247 | 253 | PF00498 | 0.516 |
LIG_FHA_1 | 258 | 264 | PF00498 | 0.375 |
LIG_FHA_2 | 37 | 43 | PF00498 | 0.513 |
LIG_LIR_Gen_1 | 94 | 102 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 101 | 107 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.416 |
LIG_SH2_NCK_1 | 105 | 109 | PF00017 | 0.513 |
LIG_SH2_SRC | 76 | 79 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.411 |
LIG_SH3_1 | 226 | 232 | PF00018 | 0.540 |
LIG_SH3_3 | 132 | 138 | PF00018 | 0.478 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.728 |
LIG_SH3_3 | 226 | 232 | PF00018 | 0.643 |
LIG_SUMO_SIM_par_1 | 259 | 264 | PF11976 | 0.585 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.513 |
LIG_WRC_WIRS_1 | 115 | 120 | PF05994 | 0.323 |
LIG_WW_2 | 229 | 232 | PF00397 | 0.541 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.654 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.513 |
MOD_Cter_Amidation | 240 | 243 | PF01082 | 0.623 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.578 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.606 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.649 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.817 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.585 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.677 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.294 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.691 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.604 |
MOD_GSK3_1 | 257 | 264 | PF00069 | 0.569 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.513 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.572 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.573 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.596 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.500 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.411 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.525 |
MOD_PIKK_1 | 246 | 252 | PF00454 | 0.535 |
MOD_PKA_1 | 36 | 42 | PF00069 | 0.513 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.731 |
MOD_PKA_2 | 246 | 252 | PF00069 | 0.535 |
MOD_PKA_2 | 36 | 42 | PF00069 | 0.513 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.436 |
MOD_Plk_1 | 110 | 116 | PF00069 | 0.580 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.587 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.454 |
MOD_Plk_4 | 257 | 263 | PF00069 | 0.474 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.513 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.562 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.355 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.349 |
TRG_DiLeu_BaEn_1 | 94 | 99 | PF01217 | 0.411 |
TRG_DiLeu_BaEn_2 | 60 | 66 | PF01217 | 0.411 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.513 |
TRG_ER_diArg_1 | 125 | 127 | PF00400 | 0.640 |
TRG_ER_diArg_1 | 242 | 244 | PF00400 | 0.602 |
TRG_ER_diArg_1 | 277 | 280 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 36 | 38 | PF00400 | 0.513 |
TRG_Pf-PMV_PEXEL_1 | 41 | 45 | PF00026 | 0.436 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4Z1 | Leptomonas seymouri | 57% | 100% |
A0A3S5H729 | Leishmania donovani | 89% | 100% |
A4H9F7 | Leishmania braziliensis | 77% | 100% |
A4HXS4 | Leishmania infantum | 89% | 100% |
Q4QDZ3 | Leishmania major | 90% | 100% |